首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Use of desmopressin as an alternative to corticotropin-releasing hormone during inferior petrosal sinus sampling in a child with Cushing's disease.
【24h】

Use of desmopressin as an alternative to corticotropin-releasing hormone during inferior petrosal sinus sampling in a child with Cushing's disease.

机译:使用去吡啉作为皮质培养素释放激素的替代方法在较低的岩石鼻窦中的替代品,在患有缓冲疾病的儿童中。

获取原文
获取原文并翻译 | 示例

摘要

Cushing's syndrome (CS) is rare in children. Information on bilateral inferior petrosal sinus sampling (BIPSS) in children with CS is limited. In the procedure CRH is always used to stimulate ACTH values. In addition, growth failure is the main complication of pediatric CS, mainly due to a profound GH suppression that persists for a few months after cure of the disease. Early treatment with recombinant GH after CS cure may partly reverse this phenomenon. We report herein a case of Cushing's disease (CD) in a 7-yr-old child, presenting with severe growth failure. No pituitary adenoma was shown on magnetic resonance imaging and a BIPSS using desmopressin allowed the identification of a central to peripheral (C/P) gradient; however transphenoidal surgery (TSS) did not cure the disease thus requiring the performance of bilateral adrenalectomy. After cure of the disease, a partial catch up of the growth delay occurred without any GH treatment. Our case reinforces the fact that BIPSS can be performed safely in very young children with CD. It also suggests for the first time that the use of desmopressin during the procedure gives the same information as CRH, as well as confirming the fact that the success of TSS is poor in very young children. Finally, it suggests that growth failure in children with CS can be partially reversed after surgical cure of the disease without any GH treatment and that the high IGF-I observed during corticosteroid replacement therapy is due to a state of IGF-I resistance.
机译:Cushing的综合症(CS)是罕见的儿童。有关CS儿童的双侧劣质岩石窦取样(Bripss)的信息有限。在手术中,CRH始终用于刺激ACTH值。此外,生长衰竭是儿科CS的主要并发症,主要是由于疾病治愈后几个月持续存在的深刻GH抑制。通过CS治疗后重组GH的早期治疗可能部分逆转这种现象。我们在本文中报告了一个7岁儿童中的缓冲疾病(CD),呈现严重的生长衰竭。在磁共振成像上没有显示垂体腺瘤,并且使用去倒素的堆均允许鉴定外周(C / P)梯度的中心;然而,单分体手术(TSS)未治愈疾病,从而需要进行双侧肾上腺切除术的性能。在治愈该疾病后,发生了一部分的生长延迟而没有任何GH治疗。我们的案例强化了百品可以在非常幼儿中安全地在CD中进行安全。它还建议首次在程序期间使用去倒子提供与CRH相同的信息,并确认TSS成功在非常幼儿中的成功。最后,它表明,在没有任何GH治疗的情况下,在疾病的外科治疗后,CS的儿童的生长失败可以部分逆转,并且在皮质类固醇替代治疗期间观察到的高IGF-I是由于IGF-I的抵抗状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号